Literature DB >> 12887307

Structure of human BPI (bactericidal/permeability-increasing protein) and implications for related proteins.

L J Beamer1.   

Abstract

Human bactericidal/permeability-increasing protein (BPI) belongs to a family of mammalian lipopolysaccharide-binding and lipid transport proteins. Recent sequence database searches indicate that several other protein families, including the palate, lung and nasal epithelial clone (PLUNC), parotid secretory protein (PSP) and BPI-like proteins, are likely to share the BPI fold, which was determined through X-ray crystallographic studies. As the single representative of its fold family of known structure, the three-dimensional model of BPI suggests structural features that are likely to be conserved across this large and varied group of proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887307     DOI: 10.1042/bst0310791

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  12 in total

1.  Fluoxetine-resistance genes in Caenorhabditis elegans function in the intestine and may act in drug transport.

Authors:  Robert K M Choy; John M Kemner; James H Thomas
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

2.  Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP).

Authors:  Meng Zhang; Xiaobo Zhai; Jinping Li; John J Albers; Simona Vuletic; Gang Ren
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-06-05       Impact factor: 4.698

3.  The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623).

Authors:  Natalie L Trevaskis; Claire L McEvoy; Michelle P McIntosh; Glenn A Edwards; Ravi M Shanker; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2010-03-11       Impact factor: 4.200

4.  Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.

Authors:  Amit Srivastava; Heather Casey; Nathaniel Johnson; Ofer Levy; Richard Malley
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

5.  The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles.

Authors:  Natalie L Trevaskis; Ravi M Shanker; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2010-07-16       Impact factor: 4.200

6.  A Teleost Bactericidal Permeability-Increasing Protein Kills Gram-Negative Bacteria, Modulates Innate Immune Response, and Enhances Resistance against Bacterial and Viral Infection.

Authors:  Yuan-Yuan Sun; Li Sun
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

7.  Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis.

Authors:  Liliane R Alves; Alberto Orfao; Fabiana V Mello; Marcelo G P Land; Elaine S Costa; Cristina Teodósio; María-Luz Sanchez; Paloma Bárcena; Rodrigo T Peres; Carlos E Pedreira
Journal:  Cell Death Discov       Date:  2019-02-28

Review 8.  Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; William F C Rigby
Journal:  J Transl Autoimmun       Date:  2021-05-28

9.  The C-terminal Domain Supports a Novel Function for CETPI as a New Plasma Lipopolysaccharide-Binding Protein.

Authors:  Victor García-González; Nadia Gutiérrez-Quintanar; Jaime Mas-Oliva
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

10.  CETP Lowers TLR4 Expression Which Attenuates the Inflammatory Response Induced by LPS and Polymicrobial Sepsis.

Authors:  Tatiana Martins Venancio; Roberta Marcondes Machado; Angela Castoldi; Mariane Tami Amano; Valeria Sutti Nunes; Eder Carlos Rocha Quintao; Niels Olsen Saraiva Camara; Francisco Garcia Soriano; Patrícia Miralda Cazita
Journal:  Mediators Inflamm       Date:  2016-05-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.